Nature nanotechnology

How mRNA Medicines Work, How They Are Delivered, Regulated, and Made Fairly Available Worldwide

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated

Full Text

Full text is available at the source.
View Full Text ↗

Related papers

Jan '26
Changes in COVID-19 antibody levels and types after multiple doses and different vaccine combinations
top 5% journal
cited by 1 paper
journal article
Feb '22
Antibody responses to longer and mixed COVID-19 mRNA vaccine doses in frail older adults
top 1% journal
cited by 15 papers
observational study

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free

Recent issues from the mrna technology brief

issue #47
Engineers used AI to design a self-destruct switch that kills virus-infected cells on command
-1 days ago7 studies
issue #46
A simple ligand swap redirected liver-targeting nanoparticles to the lungs with 200-fold more mRNA delivery
6 days ago7 studies
issue #45
A $1 device delivers naked mRNA vaccines as effectively as lipid nanoparticles in mice and human skin
1 week ago7 studies
issue #44
Light-activated lipid nanoparticles spin their way out of cellular traps to boost cancer vaccine results
2 weeks ago7 studies
issue #43
A common antibiotic switches self-amplifying RNA vaccines on and off — with 10x range between states
3 weeks ago7 studies
issue #42
A single LNP dose achieved 49% liver gene editing in mice — without viral vectors
4 weeks ago7 studies
issue #41
Buffer choice affects mRNA vaccine performance by 40% after freeze-thaw cycles
5 weeks ago7 studies
issue #40
mRNA vaccine boosted cancer immunotherapy survival rates by 70-80% in mice
6 weeks ago7 studies
issue #39
Combo flu-COVID mRNA vaccine shows durable immunity through 6 months in adults 50+
7 weeks ago7 studies
issue #38
Heart gene editing reaches 36% of muscle cells with targeted injection approach
8 weeks ago7 studies
explore the archive
See more issues from the mrna technology brief